Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: J Urol. 2015 Nov 17;195(5):1476–1481. doi: 10.1016/j.juro.2015.11.027

Table 2.

Comparison of Blood Chemistry Tests and Urinary Analyte Excretion

Parametera Placebo (n= 20) Tolvaptan (n= 19) P*
Serum Na (mEq/L) 141±2 142±3 0.005
Serum K (mEq/L) 4.1±0.5 4.0±0.5 0.34
Serum Cl (mEq/L) 102±3 102±3 0.33
Serum Bicarb (mEq/L) 28±3 27±3 0.29
Serum BUN (mg/dL) 15±4 14±5 0.27
Serum Cr (mg/dL) 0.9±0.2 0.9±0.2 0.21
Urine volume (ml/24h) 1833±900 4794±2866 <0.001
Urine pH 6.3±0.6 6.5±0.4 0.34
Osmolarity, mOsm/kg 529±213 204±96 <0.001
Ammonia (mmol/24h) 33±38 26±15 0.93
Calcium (mg/24h) 148±106 106±55 0.25
Chloride (mmol/24h) 108±72 91±44 0.39
Citrate (mg/24h) 413±267 391±209 0.73
Creatinine (mg/24h) 1096±1088 838±321 0.80
Magnesium (mg/spec) 76±53 87±42 0.26
Oxalate (mg/24h) 15±8 23±8 0.009
Phosphate (mg/24h) 714±814 560±306 0.77
Potassium (mmol/24h) 46±46 51±31 0.28
Sodium (mmol/24h) 111±56 97±55 0.35
Uric acid (mg/24h) 473±372 384±218 0.47
Calcium oxalate SS (DG) 0.95±0.87 −0.01±1.14 <0.001
Calcium phosphate (BR) SS (DG) −0.13±1.02 −1.66±1.17 <0.001
Uric acid SS (DG) −2.05±4.05 −5.24±3.12 0.04

Abbreviations: DG, delta Gibbs; SS, supersaturation.

a

All values presented as mean±s.d., unless otherwise specified.

*

P values were analyzed using wilcoxon matched-pairs signed-ranks tests in 19 patients who completed crossover study.